The global spine biologics market to grow at CAGR of 4.1% through 2022: 3 things to know

The global spine biologics market is forecasted to grow at a compound annual growth rate of 4.09 percent between 2018 and 2022, according to a Technavio report.

Advertisement

Here are three things to know:

1. A growing geriatric population will propel the market.

2. A key market trend is the increasing adoption of minimally invasive surgical procedures.

3. Key vendors include:

  • Alphatec Spine
  • Globus Medical
  • Medtronic
  • NuVasive

More articles on biologics:

DiscGenics treats 1st patient in degenerative disc disease clinical trial: 5 things to know

3 things to know about Organogenesis

Study: Single-injection durolane hylauronic acid safe, effective treatment for knee osteoarthritis

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.